drugset / Trial / NCT00104663
PRION-1: Quinacrine for Human Prion Disease
Non-randomizedSingle-groupOpen-labelTreatment
Summary
PRION-1 aims to assess the activity and safety of Quinacrine (Mepacrine hydrochloride) in human prion disease. It also aims to establish an appropriate framework for the clinical assessment of therapeutic options for human prion disease that can be refined or expanded in the future, as new agents become available.
Timeline
- Start
- 2004-06
- Primary completion
- —
- Completion
- 2007-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quinacrine | Small molecule | — | — |